<DOC>
	<DOCNO>NCT00368290</DOCNO>
	<brief_summary>The purpose study determine modafinil promote cocaine abstinence reduces high risk behavior cocaine dependent subject .</brief_summary>
	<brief_title>Modafinil Treatment Cocaine Dependence HIV High-Risk Behavior</brief_title>
	<detailed_description>The purpose study determine modafinil promote cocaine abstinence reduces HRB cocaine dependent subject . Modafinil ( 300 mg/day ) placebo administer 8-week double-blind trial patient meet diagnostic criterion cocaine dependence conjunction Cognitive Behavioral Therapy ( CBT ) .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>1 . 18 60 year ; 2 . Current DSMIV diagnosis cocaine dependence ; 3 . Using cocaine least 8 day consecutive 30 day period 60 day period immediately precede study entry ( If subject receive inpatient substance abuse treatment within 30 day prior screen , subject must use cocaine least 8 day consecutive 30 day period 60 day period immediately precede admission inpatient treatment ) ; 4 . ) Having negative urine toxicology ( BE ) test screening ( le 5 day prior randomization ) negative urine toxicology ( BE ) test day randomization . Repeat test allow require negative BE result obtain ; 4 . Able provide write informed consent comply study procedure ; 5 . Women must surgically sterile , least two year postmenopausal , , childbearing potential , use medically accept method birth control agree continue use method least 30 day last dose study drug ( i.e . barrier method spermicide , steroidal contraceptive [ oral implant , include DepoProvera , contraceptives must use conjunction barrier method ] , intrauterine device [ IUD ] ) . 1 . Currently dependent substance cocaine nicotine ; 2 . Current Neurological psychiatric disorder , psychosis , bipolar illness , organic brain disease , dementia , diseases require psychotropic medication ; 3 . Serious medical illness , include limit ; uncontrolled hypertension , significant heart disease ( include history myocardial infarction , angina , mitral valve prolapse , leave ventricular hypertrophy , palpitation , arrhythmia ) , hepatic disease , renal disease , serious , potentially lifethreatening progressive medical illness may compromise patient safety study conduct ; 4 . Received drug know potential toxicity major organ system within month prior enter treatment include , limited : chemotherapeutic agent neoplastic disease ( i.e . methotrexate , vincristine , vinblastine , fluorouracil ) , agent use parasitic infection , isoniazid , chlorambucil , dactinomycin , chloramphenicol , immunosuppressive cytotoxic agent ( i.e . cyclosporine , tacrolimus ) , indomethacin , protease inhibitor , amphotericin B , cephalosporins , aminoglycosides , interferon , sulfonamide ; 5 . Clinically significant abnormal laboratory value ( see Appendix A ) ; 6 . Has disease gastrointestinal system , liver , kidney could result altered metabolism excretion study medication ( history major gastrointestinal tract surgery , gastrectomy , gastrostomy , bowel resection , etc . ) history chronic gastrointestinal disorder ( ulcerative colitis , regional enteritis , gastrointestinal bleeding ) ; 7 . Known hypersensitivity allergy modafinil , receive chronic therapy medication could interact adversely modafinil , include propranolol , phenytoin , warfarin diazepam ; 8 . Took monoamine oxidase inhibitor ( MAOI ) within 30 day prior randomization ; 9 . Taking take investigational drug within 60 day prior randomization ; 10 . If female childbearing capacity , test positive urine pregnancy test , lactating , three day amenorrhea beyond expect menses time first dose study medication , contemplate pregnancy next 6 month , use effective contraceptive method ; 11 . Received therapy opiatesubstitute ( methadone , LAAM , buprenorphine ) within 60 day study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>cocaine dependence</keyword>
	<keyword>hiv prevention</keyword>
</DOC>